Trade LENZ stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
LENZ Therapeutics, Inc. (LENZ) is trading at US$4.08, up 0.25% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$147.05M. Over the past 52 weeks, LENZ has traded between US$4.00 and US$50.40. On Syfe you can trade LENZ with $0 commission and add it to your watchlist.
| Previous close | US$4.07 |
|---|---|
| Market cap | US$147.05M |
| 52-week range | US$4.00 – US$50.40 |
| Volume | 776.63K |
| Exchange | US |
Add to Watchlist
Set Price Alert
LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.
Year: 2024
LENZ Therapeutics to Receive VIZZ Payments From Everest-Corxel Deal
Jun 8, 8:01 AM · MT Newswires
Top Midday Decliners
May 12, 5:59 PM · MT Newswires
Piper Sandler Downgrades LENZ Therapeutics to Neutral From Overweight, Adjusts Price Target to $12 From $39
May 12, 11:35 AM · MT Newswires
Lenz Therapeutics Applies for Marketing Authorization in UK for Presbyopia Eye-Drop Treatment
Apr 20, 12:54 PM · MT Newswires
Lenz Therapeutics Insider Bought Shares Worth $251,411, According to a Recent SEC Filing
Mar 30, 12:55 PM · MT Newswires
LENZ Therapeutics, Inc. (LENZ) stock is trading at US$4.08, +0.25% from the previous close of US$4.07.
The market cap for LENZ Therapeutics, Inc. (LENZ) stock is approximately US$147.05M.
The 52-week high for LENZ Therapeutics, Inc. (LENZ) stock is US$50.40.
The 52-week low for LENZ Therapeutics, Inc. (LENZ) stock is US$4.00.
LENZ Therapeutics, Inc. (LENZ) does not currently pay a dividend.
Stay on top of LENZ
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
